GLP-1 clinical trials in Iowa: 10 recruiting now

11 sites in 4 Iowa cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (2)

Weight-loss study of cagrisema

Where: West Des Moines

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

Iowa Diabetes Research, West Des Moines

Type 2 diabetes studies (3)

Type 2 diabetes study of cagrisema

Where: Iowa City

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Children and teens 10 to 18 with type 2 diabetes.

Study record on ClinicalTrials.gov

University of Iowa, Iowa City

Type 2 diabetes study of semaglutide

Where: Ames

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Ames

Type 2 diabetes study of cagrisema

Where: West Des Moines

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 25+.

Study record on ClinicalTrials.gov

Iowa Diabetes & Endo Res Ctr, West Des Moines

Other GLP-1 studies in Iowa (5)

Fatty liver disease with liver scarring study of survodutide

Where: Clive and West Des Moines

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Iowa Digestive Disease Center, Clive. 833-602-2368

Iowa Diabetes and Endocrinology Research Center, West Des Moines. 833-602-2368

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: West Des Moines

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

Iowa Diabetes and Endocrinology Research Center, West Des Moines. 833-602-2368

Fatty liver disease (MASLD) study of retatrutide

Where: West Des Moines

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Study record on ClinicalTrials.gov

Iowa Diabetes and Endocrinology Research Center, West Des Moines

Show 2 more studies

Prehypertension study of orforglipron

Where: West Des Moines

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.

Free to join

Who can join: Adults 18+ who are overweight, BMI 25+.

Call the site: 515-329-6800Study record on ClinicalTrials.gov

Iowa Diabetes and Endocrinology Research Center, West Des Moines. 515-329-6800

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.